Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations
02 Aug 2024 //
PR NEWSWIRE
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
10 Jul 2024 //
PR NEWSWIRE
Perrigo agrees to sell rare disease unit to Esteve for €275 million
26 Apr 2024 //
PRESS RELEASE
Perrigo to Divest HRA Pharma Rare Diseases for Up to €275M
25 Apr 2024 //
PR NEWSWIRE